Sox4 is a key oncogenic target in C/EBP? mutant Acute Myeloid Leukemia
收藏官方服务：
资源简介：
Sox4 is a key oncogenic target in C/EBP? mutant Acute Myeloid Leukemia
应用场景：
创建时间：
2013-03-23
相关数据集
An Integrated Approach to Patient Stratification and Therapy Selection in Acute Myeloid Leukemia
As more clinically-relevant genomic features of myeloid malignancies are revealed, it has become clear that targeted clinical genetic testing is inadequate for risk stratification. Here, we developed
NIAID Data Ecosystem70
MOESM6 of Reduced protocadherin17 expression in leukemia stem cells: the clinical and biological effect in acute myeloid leukemia
Additional file 6. Differentially expressed microRNAs between AML patients with low and high PCDH17 expression.
Figshare2024-02-07 更新40
A PRC2-KDM5B-stemness regulatory axis sustains tumorigenicity of acute myeloid leukemia [ChIP-Seq]
Acute myeloid leukemias (AMLs) with the NUP98-NSD1 or MLL gene rearrangement (MLL-r) share transcriptomic profiles featured with stemness-related gene signatures and display poor prognosis in the clin
NIAID Data Ecosystem30
NPM1c hijacks the active trancription in leukemia development [RNA-Seq]
Nucleophosmin (NPM1) is a ubiquitously expressed nucleolar protein with a wide range of functions including ribosome biogenesis, mRNA processing, and maintenance of genomic stability1-4. In acute myel
NIAID Data Ecosystem50
MicroRNA-155 is upregulated in Hoxa9/Meis1 leukemia inducing cells but is dispensable for in vivo transformation and leukemia development. Mus musculus
OBJECTIVE: The microRNA miR-155 is upregulated in Hoxa9 and Meis1 leukemia inducing cells (LIC) , and miR-155 accelerates the onset of acute myeloid leukemia (AML) together with Hoxa9 but through larg
NIAID Data Ecosystem40
